Facebook
Twitter
Telegram
Fehler meldenAclaris Therapeutics Finanzdaten 2011-2024 | ACRS
Jahresabschluß Aclaris Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
83.8 M | 832 M | 825 M | 275 M | 54.5 M | 231 M | 634 M | 559 M | 136 M | - | - | - | - |
Anteile |
69.8 M | 65.2 M | 56.7 M | 42.5 M | 41.3 M | 32.9 M | 28.1 M | 21.4 M | 6.11 M | - | - | - | - |
Kurshistorie |
1.2 | 12.8 | 14.5 | 6.47 | 1.89 | 7.39 | 24.7 | 27.1 | 26.9 | - | - | - | - |
Nettogewinn |
-88.5 M | -86.9 M | -90.9 M | -51 M | -161 M | -133 M | -68.5 M | -48.1 M | -20.6 M | -8.52 M | -5.24 M | - | - |
Umsatz |
31.2 M | 29.8 M | 6.76 M | 6.48 M | 4.23 M | 10.1 M | 1.68 M | - | - | - | - | - | - |
Umsatzkosten |
3.42 M | 4.02 M | 4.71 M | 5.13 M | 4.06 M | 4.33 M | 1.21 M | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | 172 K | 3.24 M | 476 K | - | - | - | - | - | - |
Betriebsergebnis |
-97.4 M | -89.9 M | -89.7 M | -50.9 M | -111 M | -84.8 M | -54.4 M | -48.6 M | -20.7 M | -8.53 M | -5.26 M | - | - |
Zinsaufwendungen |
8.51 M | 2.95 M | -1.14 M | -424 K | -2.48 M | 2.68 M | 2.07 M | 488 K | 104 K | 16 K | - | - | - |
EBITDA |
-96.5 M | -89.1 M | -88.8 M | -49.6 M | -86.1 M | -132 M | -72 M | -48.4 M | -20.6 M | -8.52 M | -5.25 M | - | - |
Betriebsaufwand |
- | - | - | - | 92.7 M | 137 M | 72.9 M | 48.6 M | 20.7 M | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
32.4 M | 25.1 M | 23.6 M | 20.5 M | 27.2 M | 26.1 M | 33.1 M | 15.1 M | 5.33 M | 2.03 M | 1.77 M | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Aclaris Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
71.1 M | 70.9 M | 70.8 M | 70.6 M | 66.9 M | 66.7 M | 66.7 M | 66 M | 61.4 M | 61.2 M | 61.2 M | 54 M | 50.3 M | 45.1 M | 42.8 M | 42.1 M | 41.6 M | 41.5 M | 41.4 M | 41.3 M | 41.2 M | 41.2 M | 31 M | 30.9 M | 30.9 M | 30.9 M | 28.8 M | 26.6 M | 26.1 M | 26.1 M | 21.4 M | 20.7 M | 20.2 M | 20.2 M | 2.27 M | 2.15 M | 2.03 M | 2.73 M | 1.79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-16.9 M | - | -29.3 M | -29.6 M | -28.2 M | - | -20 M | -20.5 M | -18.8 M | - | -21.1 M | -18.2 M | -28.8 M | - | -10.7 M | -11.6 M | -15.6 M | - | -55.3 M | -49.9 M | -37.6 M | -38.6 M | -32.7 M | -31.2 M | -30.2 M | -22.9 M | -18.2 M | -14.8 M | -12.6 M | -11.5 M | -10.7 M | -12.9 M | -13 M | -4.71 M | -10.6 M | -2.59 M | -2.62 M | -2.6 M | -2.66 M | -2.23 M | -1.03 M | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatz |
2.4 M | - | 9.28 M | 1.87 M | 2.53 M | - | 19 M | 1.53 M | 1.45 M | - | 1.66 M | 1.82 M | 1.78 M | - | 1.45 M | 2.05 M | 1.41 M | - | 983 K | 886 K | 1.26 M | 3.67 M | 1.12 M | 3.68 M | 1.12 M | 999 K | 684 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
809 K | - | 848 K | 1.04 M | 808 K | - | 923 K | 1.07 M | 1.16 M | - | 1.1 M | 1.26 M | 1.2 M | - | 1.19 M | 1.39 M | 1.27 M | - | 826 K | 994 K | 1.21 M | - | 1.07 M | 1.18 M | 967 K | - | 453 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 160 K | 435 K | 2.5 M | 151 K | 245 K | 231 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-18.9 M | - | -31.6 M | -31.8 M | -29.9 M | - | -20.9 M | -21 M | -18.9 M | - | -20.3 M | -18 M | -28.5 M | - | -10.5 M | -11.4 M | -15.5 M | - | -22.9 M | -43.6 M | -27.1 M | - | -21.3 M | -32 M | -30.9 M | - | -18.8 M | -15.3 M | -12.9 M | - | -10.8 M | -13 M | -13.1 M | - | -10.6 M | -2.6 M | -2.63 M | - | -2.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
1.99 M | - | 2.32 M | 2.25 M | 1.76 M | - | 922 K | 462 K | 118 K | - | -851 K | -155 K | -225 K | - | -194 K | -189 K | 178 K | - | -274 K | -85 K | -230 K | - | 710 K | 760 K | 719 K | - | 564 K | 457 K | 371 K | - | 118 K | 118 K | 100 K | - | 7 K | - | - | - | 5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-18.7 M | - | -31.4 M | -31.6 M | -29.7 M | - | -20.7 M | -20.8 M | -18.7 M | - | -19.6 M | -17.8 M | -28.2 M | - | -8.69 M | -10.2 M | -14.9 M | - | -16.8 M | -39.1 M | -24.8 M | - | -20.4 M | -31.4 M | -30.7 M | - | -18.5 M | -15.2 M | -12.9 M | - | -10.7 M | -13 M | -13.1 M | - | -10.6 M | -2.57 M | -2.63 M | - | -2.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.2 M | 33.9 M | 34.5 M | 31.1 M | 25.7 M | 19 M | 15.3 M | 12.9 M | 11.6 M | 10.8 M | 13 M | 13.1 M | 4.8 M | 10.6 M | 2.6 M | 2.63 M | 2.6 M | 2.66 M | 2.23 M | 1.04 M | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
6.84 M | - | 7.09 M | 8.32 M | 8.79 M | - | 5.81 M | 6.08 M | 6.1 M | - | 5.98 M | 5.87 M | 4.83 M | - | 3.86 M | 5.57 M | 6.2 M | - | 6.84 M | 7.47 M | 7.46 M | - | 6.14 M | 8.12 M | 6.26 M | - | 4.57 M | 5.14 M | 3.72 M | - | 3.65 M | 3.15 M | 3.6 M | - | 1.23 M | 803 K | 892 K | - | 565 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung